ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
6300 | |||||
(Address of Principal Executive Offices) | (Zip Code) | ||||
Title of each class | Trading symbols(s) | Name of exchange on which registered |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |
☒ | Smaller reporting company | |||
Emerging growth company |
ITEM | PAGE |


Reserves | |||||||||||||||||
Proven | Probable | Total | |||||||||||||||
(In millions of tons, except percentage data) | Total | Hard Rock | Sand & Gravel | Total | Hard Rock | Sand & Gravel | Total | Hard Rock | Sand & Gravel | ||||||||
Aggregates | |||||||||||||||||
United States | 1,395 | 82% | 18% | 2,178 | 98% | 2% | 3,573 | 91% | 9% | ||||||||
Canada | 1,002 | 92% | 8% | 1,594 | 87% | 13% | 2,596 | 89% | 11% | ||||||||
Subtotal | 2,397 | 86% | 14% | 3,772 | 93% | 7% | 6,169 | 90% | 10% | ||||||||
Cement | |||||||||||||||||
United States | 1,466 | 100% | 152 | 100% | 1,618 | 100% | |||||||||||
Canada | 89 | 100% | 344 | 100% | 433 | 100% | |||||||||||
Subtotal | 1,555 | 100% | 496 | 100% | 2,051 | 100% | |||||||||||
Total | 3,952 | 92% | 8% | 4,268 | 94% | 6% | 8,220 | 93% | 7% | ||||||||

Resources | |||||||||||||||||||||||||
Measured | Indicated | Total Measured & Indicated | Inferred | Total | |||||||||||||||||||||
(In millions of tons, except percentage data) | Total | Hard Rock | Sand & Gravel | Total | Hard Rock | Sand & Gravel | Total | Hard Rock | Sand & Gravel | Total | Hard Rock | Sand & Gravel | |||||||||||||
Aggregates | |||||||||||||||||||||||||
United States | 779 | 64% | 36% | 537 | 90% | 10% | 1,316 | 74% | 26% | 1,004 | 90% | 10% | 2,320 | ||||||||||||
Canada | 126 | 60% | 40% | 787 | 81% | 19% | 913 | 78% | 22% | 2,046 | 77% | 23% | 2,959 | ||||||||||||
Subtotal | 905 | 63% | 37% | 1,324 | 85% | 15% | 2,229 | 76% | 24% | 3,050 | 81% | 19% | 5,279 | ||||||||||||
Cement | |||||||||||||||||||||||||
United States | 167 | 100% | 496 | 100% | 663 | 100% | 143 | 100% | 806 | ||||||||||||||||
Canada | 7 | 100% | 7 | 100% | 320 | 100% | 327 | ||||||||||||||||||
Subtotal | 167 | 100% | 503 | 100% | 670 | 100% | 463 | 100% | 1,133 | ||||||||||||||||
Total | 1,072 | 69% | 31% | 1,827 | 89% | 11% | 2,899 | 82% | 18% | 3,513 | 84% | 16% | 6,412 | ||||||||||||
Additional Info | |||||||||||||||
No. of Sites | Extraction (in millions of tons) | ||||||||||||||
Total | Owned | Leased | Owned & Leased | 2025 | 2024 | 2023 | Years to Depletion1 | ||||||||
Aggregates | |||||||||||||||
United States | 147 | 88 | 51 | 8 | 63 | 61 | 63 | 58 | |||||||
Canada | 229 | 151 | 63 | 15 | 57 | 60 | 65 | 43 | |||||||
Subtotal | 376 | 239 | 114 | 23 | 120 | 121 | 128 | 50 | |||||||
Cement | |||||||||||||||
United States | 12 | 12 | 0 | 0 | 23 | 25 | 25 | 68 | |||||||
Canada | 4 | 3 | 1 | 0 | 5 | 5 | 5 | 81 | |||||||
Subtotal | 16 | 15 | 1 | 0 | 28 | 30 | 30 | 70 | |||||||
Total | 392 | 254 | 115 | 23 | 148 | 151 | 158 | ||||||||
Name | Age | Position | ||
Jan Philipp Jenisch | 59 | Chief Executive Officer and Chairman | ||
Roald Brouwer | 51 | Chief Technology Officer | ||
Stephen Clark | 57 | Chief People Officer | ||
Nollaig Forrest | 49 | Chief Marketing and Corporate Affairs Officer | ||
Jake Gosa | 50 | President, Building Envelope | ||
Mario Gross | 47 | Chief Supply Chain Officer | ||
Jaime Hill | 56 | President, Building Materials | ||
Ian Johnston | 51 | Chief Financial Officer | ||
Samuel J. Poletti | 44 | Chief Strategy and M&A Officer | ||
Denise R. Singleton | 63 | Chief Legal Officer and Corporate Secretary |
Plan Category | (A) Number of securities to be issued upon exercise of outstanding options, warrants and rights | (B) Weighted-average exercise price of outstanding options, warrants and rights | (C) Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (A) |
Equity compensation plans approved by security holders | 3,913,655(1) | $ 31.98(2) | 32,886,345(3) |
Equity compensation plans not approved by security holders(4) | — | — | — |
Total | 3,913,655 | $ 31.98 | 32,886,345 |

Comparative Total Return1 | June 23, 2025 | June 30, 2025 | September 30, 2025 | December 31, 2025 |
Amrize Ltd | $100.00 | $95.31 | $93.34 | $104.02 |
S&P 500 Index | 100.00 | 102.95 | 111.31 | 114.27 |
S&P 500 Materials Index | 100.00 | 101.00 | 103.57 | 105.35 |
For the years ended December 31, | |||
$ in millions, except percentage data | 2025 | 2024 | 2023 |
Revenues | $11,815 | $11,704 | $11,677 |
Net income | $1,182 | $1,273 | $955 |
Net income margin | 10.0% | 10.9% | 8.2% |
Adjusted EBITDA | $3,007 | $3,181 | $2,844 |
Adjusted EBITDA Margin | 25.5% | 27.2% | 24.4% |
Cash flows provided by operating activities | $2,208 | $2,282 | $2,036 |
For the years ended December 31, | ||||||||||
(In millions, except for percentage data) | 2025 | 2024 | 2023 | 2025 vs 2024 % change | 2024 vs 2023 % change | |||||
Revenues | $11,815 | $11,704 | $11,677 | 0.9% | 0.2% | |||||
Cost of revenues | (8,781) | (8,634) | (8,908) | 1.7% | (3.1)% | |||||
Gross profit | 3,034 | 3,070 | 2,769 | (1.2)% | 10.9% | |||||
Selling, general and administrative expenses | (1,128) | (944) | (898) | 19.5% | 5.1% | |||||
Gain on disposal of long-lived assets | 15 | 71 | 32 | n/m | n/m | |||||
Loss on impairments | (15) | (2) | (15) | n/m | n/m | |||||
Operating income | 1,906 | 2,195 | 1,888 | (13.2)% | 16.3% | |||||
Interest expense, net | (413) | (512) | (549) | (19.3)% | (6.7)% | |||||
Other non-operating income (expense), net | 4 | (55) | (36) | n/m | n/m | |||||
Income before income tax expense and income from equity method investments | 1,497 | 1,628 | 1,303 | (8.0)% | 24.9% | |||||
Income tax expense | (326) | (368) | (361) | (11.4)% | 1.9% | |||||
Income from equity method investments | 11 | 13 | 13 | (15.4)% | —% | |||||
Net income | 1,182 | 1,273 | 955 | (7.1)% | 33.3% | |||||
Net loss attributable to noncontrolling interests | 3 | 1 | 1 | n/m | —% | |||||
Net income attributable to the Company | $1,185 | $1,274 | $956 | (7.0)% | 33.3% | |||||
Net income margin | 10.0% | 10.9% | 8.2% | |||||||
Adjusted EBITDA(1) | $3,007 | $3,181 | $2,844 | (5.5)% | 11.8% | |||||
Adjusted EBITDA Margin(1) | 25.5% | 27.2% | 24.4% | |||||||
Analysis of Change | ||||||||||||
(In millions, except for percentage data) | For the year ended December 31, 2024 | Acquisitions & Divestments | Organic Growth | Foreign Exchange | For the year ended December 31, 2025 | % change | ||||||
Total Revenues | $11,704 | $130 | $34 | $(53) | $11,815 | 0.9% | ||||||
Adjusted EBITDA(1) | 3,181 | 22 | (181) | (15) | 3,007 | (5.5)% | ||||||
Adjusted EBITDA Margin(1) | 27.2% | 25.5% | ||||||||||
Analysis of Change | ||||||||||||
(In millions, except for percentage data) | For the year ended December 31, 2023 | Acquisitions & Divestments | Organic Growth | Foreign Exchange | For the year ended December 31, 2024 | % change | ||||||
Total Revenues | $11,677 | $118 | $(48) | $(43) | $11,704 | 0.2% | ||||||
Adjusted EBITDA(1) | 2,844 | 14 | 334 | (11) | 3,181 | 11.8% | ||||||
Adjusted EBITDA Margin(1) | 24.4% | 27.2% | ||||||||||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | % change | |||
Segment revenues: | ||||||
Building Materials(1) | $8,514 | $8,329 | 2.2% | |||
Building Envelope | 3,301 | 3,375 | (2.2)% | |||
Total revenues | $11,815 | $11,704 | 0.9% | |||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | % change | |||
Segment Adjusted EBITDA: | ||||||
Building Materials | $2,485 | $2,552 | (2.6)% | |||
Building Envelope | 732 | 770 | (4.9)% | |||
Total Segment Adjusted EBITDA | 3,217 | 3,322 | (3.2)% | |||
Unallocated corporate costs | (210) | (141) | 48.9% | |||
Adjusted EBITDA(2) | $3,007 | $3,181 | (5.5)% | |||
Volumes | For the years ended December 31, | ||
in millions | 2025 | 2024 | % Change |
Cement - tons sold1 | 22.4 | 22.6 | (0.9%) |
Aggregates - tons sold | 118.9 | 119.8 | (0.8%) |
Average Selling Price | For the years ended December 31, | |||||
$ per ton | 2025 | 2024 | % Change | Constant Currency2 | % Change Constant Currency | |
Cement - price per ton1 | $170.05 | $170.21 | (0.1%) | $170.65 | 0.3% | |
Aggregates - price per ton3 | $14.06 | $13.35 | 5.3% | $14.16 | 6.1% | |
For the years ended December 31, | ||||||
(In millions) | 2024 | 2023 | % change | |||
Segment revenues: | ||||||
Building Materials(1) | $8,329 | $8,564 | (2.7)% | |||
Building Envelope | 3,375 | 3,113 | 8.4% | |||
Total revenues | $11,704 | $11,677 | 0.2% | |||
For the years ended December 31, | ||||||
(In millions) | 2024 | 2023 | % change | |||
Segment Adjusted EBITDA: | ||||||
Building Materials | $2,552 | $2,314 | 10.3% | |||
Building Envelope | 770 | 685 | 12.4% | |||
Total Segment Adjusted EBITDA | 3,322 | 2,999 | 10.8% | |||
Unallocated corporate costs | (141) | (155) | (9.0)% | |||
Adjusted EBITDA(2) | $3,181 | $2,844 | 11.8% | |||
Volumes | For the years ended December 31, | ||
in millions | 2024 | 2023 | % Change |
Cement - tons sold1 | 22.6 | 24.4 | (7.4%) |
Aggregates - tons sold | 119.8 | 128.9 | (7.1%) |
Average Selling Price | For the years ended December 31, | |||||
$ per ton | 2024 | 2023 | % Change | Constant Currency2 | % Change Constant Currency | |
Cement - price per ton1 | $170.21 | $160.48 | 6.1% | $170.65 | 6.3% | |
Aggregates - price per ton3 | $13.35 | $12.16 | 9.8% | $13.43 | 10.4% | |
For the years ended December 31, | ||||||
(In millions, except for percentage data) | 2025 | 2024 | 2023 | |||
Net income | $1,182 | $1,273 | $955 | |||
Depreciation, depletion, accretion and amortization | 914 | 889 | 851 | |||
Interest expense, net | 413 | 512 | 549 | |||
Income tax expense | 326 | 368 | 361 | |||
EBITDA | 2,835 | 3,042 | 2,716 | |||
Acquisition and integration-related costs(1) | 64 | 46 | 30 | |||
Litigation-related costs(2) | 46 | 9 | 8 | |||
Loss on impairments(3) | 15 | 2 | 15 | |||
Restructuring and other costs(4) | 19 | 16 | 52 | |||
Spin-off and separation-related costs(5) | 43 | 24 | — | |||
Other non-operating (income) expense, net(6) | (4) | 55 | 36 | |||
Income from equity method investments | (11) | (13) | (13) | |||
Adjusted EBITDA | 3,007 | 3,181 | 2,844 | |||
Unallocated corporate costs | 210 | 141 | 155 | |||
Total Segment Adjusted EBITDA | $3,217 | $3,322 | $2,999 | |||
Building Materials | $2,485 | $2,552 | $2,314 | |||
Building Envelope | $732 | $770 | $685 | |||
Net income margin | 10.0% | 10.9% | 8.2% | |||
EBITDA Margin | 24.0% | 26.0% | 23.3% | |||
Adjusted EBITDA Margin | 25.5% | 27.2% | 24.4% | |||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Net cash provided by operating activities | $2,208 | $2,282 | $2,036 | |||
Capital expenditures, net(1) | (745) | (549) | (581) | |||
Free cash flow | $1,463 | $1,733 | $1,455 | |||
Net income | $1,182 | $1,273 | $955 | |||
Adjusted EBITDA | $3,007 | $3,181 | $2,844 | |||
Net income cash conversion ratio | 1.24 | 1.36 | 1.52 | |||
Adjusted EBITDA cash conversion ratio | 0.49 | 0.54 | 0.51 | |||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Net cash provided by (used in): | ||||||
Operating activities | $2,208 | $2,282 | $2,036 | |||
Investing activities | (361) | (1,208) | (2,025) | |||
Financing activities | (1,555) | (537) | 734 | |||
Effect of exchange rate changes on cash and cash equivalents | 45 | (59) | 11 | |||
Increase (decrease) in cash and cash equivalents | 337 | 478 | 756 | |||
Cash and cash equivalents - beginning of year | 1,585 | 1,107 | 351 | |||
Cash and cash equivalents - end of year | $1,922 | $1,585 | $1,107 | |||
(In millions) | 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | Total | |||||||
Principal on short-term and long-term debt | $333 | $701 | $701 | $1 | $1,002 | $2,529 | $5,267 | |||||||
Operating lease obligations | 164 | 137 | 104 | 86 | 60 | 246 | 797 | |||||||
Finance lease obligations | 136 | 114 | 89 | 53 | 30 | 107 | 529 | |||||||
Pension and postretirement contributions | 28 | 27 | 25 | 24 | 23 | 411 | 538 | |||||||
Purchase obligations(1) | 524 | 60 | 53 | 46 | 35 | 90 | 808 | |||||||
Total | $1,185 | $1,039 | $972 | $210 | $1,150 | $3,383 | $7,939 |
Description of the Matter | As of December 31, 2025, the Building Envelope goodwill balance was $4,026 million. As described in Notes 2 and 8 to the financial statements, goodwill is tested for impairment at least annually at the reporting unit level. The Company performed a quantitative goodwill impairment test for the reporting units in the Building Envelope segment and therefore estimated the fair market value of these reporting units. Auditing management’s quantitative impairment test for goodwill was complex and judgmental due to the significant estimation required to determine the fair value of the reporting units in the Building Envelope segment. In particular, the Company’s fair value estimates were sensitive to significant assumptions, specifically forecasted revenues, earnings before interest, taxes, depreciation and amortization (EBITDA) margins, discount rates and long-term growth rates, which are forward-looking and affected by expectations about future market and economic conditions. |
How We Addressed the Matter in Our Audit | To test the estimated fair value of the Building Envelope reporting units, we performed procedures that included, among others, assessing the reasonableness of forecasted revenues, EBITDA margins and long-term growth rates used by the Company by comparing to recent historical financial performance and external economic forecasts, and evaluating the consistency of those assumptions with other internal reporting such as the Company’s business plan. We tested the mathematical accuracy of the models used by the Company and assessed management’s ability to forecast by evaluating the historical accuracy of management’s prior estimates as compared to actual results. We performed sensitivity analyses of these significant assumptions to understand the impact of changes on the estimated fair value of the reporting units. With the assistance of our valuation specialists, we evaluated the methodologies applied and tested the discount rates used by the Company by comparing with those developed independently. |
For the years ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Revenues | $ | $ | $ | |||
Cost of revenues | ( | ( | ( | |||
Gross profit | ||||||
Selling, general and administrative expenses | ( | ( | ( | |||
Gain on disposal of long-lived assets | ||||||
Loss on impairments | ( | ( | ( | |||
Operating income | ||||||
Interest expense, net | ( | ( | ( | |||
Other non-operating income (expense), net | ( | ( | ||||
Income before income tax expense and income from equity method investments | ||||||
Income tax expense | ( | ( | ( | |||
Income from equity method investments | ||||||
Net income | ||||||
Net loss attributable to noncontrolling interests | ||||||
Net income attributable to the Company | $ | $ | $ | |||
Earnings per share attributable to the Company: | ||||||
Basic | $ | $ | $ | |||
Diluted | $ | $ | $ | |||
Weighted-average number of shares outstanding: | ||||||
Basic | ||||||
Diluted | ||||||
For the years ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Comprehensive income: | ||||||
Net income | $ | $ | $ | |||
Other comprehensive income (loss), net of tax: | ||||||
Foreign currency translation | ( | |||||
Net change in fair value of cash flow hedges, net of tax | ( | |||||
Actuarial gains (losses) and prior service credits (costs) for defined benefit pension plans and other postretirement benefit plans, net of tax | ( | |||||
Total other comprehensive income (loss), net of tax | ( | |||||
Total comprehensive income | ||||||
Comprehensive loss attributable to noncontrolling interests | ||||||
Comprehensive income attributable to the Company | $ | $ | $ | |||
As of December 31, | ||||
2025 | 2024 | |||
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | $ | $ | ||
Accounts receivable, net | ||||
Due from related-party | ||||
Inventories | ||||
Related-party notes receivable | ||||
Prepaid expenses and other current assets | ||||
Total current assets | ||||
Property, plant and equipment, net | ||||
Goodwill | ||||
Intangible assets, net | ||||
Operating lease right-of-use assets, net | ||||
Other noncurrent assets | ||||
Total Assets | $ | $ | ||
Liabilities and Equity | ||||
Current Liabilities: | ||||
Accounts payable | $ | $ | ||
Due to related-party | ||||
Current portion of long-term debt | ||||
Current portion of related-party notes payable | ||||
Operating lease liabilities | ||||
Other current liabilities | ||||
Total current liabilities | ||||
Long-term debt | ||||
Related-party notes payable | ||||
Deferred income tax liabilities | ||||
Noncurrent operating lease liabilities | ||||
Other noncurrent liabilities | ||||
Total Liabilities | ||||
Commitments and contingencies (see Note 17) | ||||
Equity | ||||
Common stock, par value of $ 2025 | ||||
Additional paid-in capital | ||||
Retained earnings | ||||
Net parent investment | ||||
Treasury stock, | ||||
Accumulated other comprehensive loss | ( | ( | ||
Total Equity attributable to the Company | ||||
Noncontrolling interests | ( | ( | ||
Total Equity | ||||
Total Liabilities and Equity | $ | $ | ||
For the years ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Cash Flows from Operating Activities: | ||||||
Net income | $ | $ | $ | |||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Depreciation, depletion, accretion and amortization | ||||||
Loss on impairments | ||||||
Share-based compensation | ||||||
Gain on disposal of long-lived assets | ( | ( | ( | |||
Gain on land expropriation | ( | |||||
Deferred tax expense (benefit) | ( | |||||
Net periodic benefit cost | ||||||
Other items, net | ||||||
Changes in operating assets and liabilities, net of effects of acquisitions: | ||||||
Accounts receivable, net | ( | ( | ||||
Due from related party | ( | |||||
Inventories | ( | ( | ( | |||
Accounts payable | ||||||
Due to related party | ( | ( | ||||
Other assets | ( | |||||
Other liabilities | ( | |||||
Defined benefit pension plans and other postretirement benefit plans | ( | ( | ( | |||
Net cash provided by operating activities | ||||||
Cash Flows from Investing Activities: | ||||||
Purchases of property, plant and equipment | ( | ( | ( | |||
Acquisitions, net of cash acquired | ( | ( | ( | |||
Proceeds from disposals of long-lived assets | ||||||
Proceeds from land expropriation | ||||||
Proceeds from property and casualty insurance | ||||||
Net decrease (increase) in short-term related-party notes receivable from cash pooling program | ( | |||||
Other investing activities, net | ( | ( | ( | |||
Net cash used in investing activities | ( | ( | ( | |||
Cash Flows from Financing Activities: | ||||||
Transfers to Holcim, net | ( | ( | ( | |||
Proceeds from issuance of long-term debt, net of discount | ||||||
Payments of debt issuance costs | ( | |||||
Net repayments of short-term related-party debt | ( | ( | ( | |||
Proceeds from debt-for-debt exchange with Holcim | ||||||
Proceeds from issuances of long-term related-party debt | ||||||
Repayments of long-term related-party debt | ( | ( | ||||
Repayments of long-term third-party debt | ( | |||||
Payments of finance lease obligations | ( | ( | ( | |||
Other financing activities, net | ( | ( | ||||
Net cash (used in) provided by financing activities | ( | ( | ||||
Effect of exchange rate changes on cash and cash equivalents | ( | |||||
Increase in cash and cash equivalents | ||||||
Cash and cash equivalents at the beginning of year | ||||||
Cash and cash equivalents at the end of year | $ | $ | $ | |||
Common stock | Treasury stock | |||||||||
Shares | Amount | Shares | Amount | Additional paid-in capital | Retained earnings | Net parent investment | Accumulated other comprehensive loss | Equity attributable to noncontrolling interest | Total equity | |
Balance as of December 31, 2022 | — | $— | — | $— | $ | $ | $ | $( | $ | $ |
Net income (loss) | — | — | — | — | — | — | — | ( | ||
Other comprehensive income, net of taxes | — | — | — | — | — | — | — | — | ||
Net transfers to Holcim | — | — | — | — | — | — | ( | — | — | ( |
Balance as of December 31, 2023 | — | — | — | — | ( | |||||
Net income (loss) | — | — | — | — | — | — | — | ( | ||
Other comprehensive loss, net of taxes | — | — | — | — | — | — | — | ( | — | ( |
Net transfers to Holcim | — | — | — | — | — | — | ( | — | — | ( |
Balance as of December 31, 2024 | — | $— | — | $— | $ | $ | $ | $( | $( | $ |
Net income (loss) | — | — | — | — | — | — | ( | |||
Other comprehensive income, net of taxes | — | — | — | — | — | — | — | |||
Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | ( | — | — | ( |
Net transfers from Holcim including Spin- off-related adjustments | — | — | — | — | — | — | — | |||
Issuance of Common stock, Treasury stock and reclassification of Net parent investment | ( | — | — | ( | — | — | ||||
Share-based compensation expense | — | — | — | — | — | — | — | — | ||
Balance as of December 31, 2025 | $ | ( | $ | $ | $ | $ | $( | $( | $ | |
Note Listing | Page |
(In millions) | 2025 | 2024 |
Cash Flow Hedges | ||
Other current assets | $ | $ |
Other current liabilities | ||
Other noncurrent liabilities |
Buildings and installations | |
Machines | |
Furniture, vehicles and tools |
Customer lists | |
Patented and unpatented technology | |
Software | |
Trademarks, brand and other marketing-related items |
Land | Indefinite |
Rail fleet and equipment | |
Machinery and equipment | |
Buildings and construction | |
Furniture and fixtures | |
Land fleet equipment |
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Building Materials | ||||||
Cement | $ | $ | $ | |||
Aggregates and other construction materials | ||||||
Interproduct revenues | ( | ( | ( | |||
Building Envelope | ||||||
Total Revenues | $ | $ | $ | |||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Central | $ | $ | $ | |||
South | ||||||
Great Lakes | ||||||
Northeast | ||||||
Pacific | ||||||
Eliminations and other(1) | ( | ( | ( | |||
Total Revenues | $ | $ | $ | |||
(In millions) | 2025 | 2024 | ||
Balance as of January 1 | $ | $ | ||
Revenue recognized | ( | ( | ||
Revenue deferred | ||||
Balance as of December 31, | $ | $ |
(In millions) | Total 2025 Acquisitions | ||
Total consideration | $ | ||
Total Assets and Liabilities Acquired | |||
Inventories, net | |||
Property, plant and equipment, net | |||
Intangible assets | |||
Other current and noncurrent assets | |||
Debt assumed | ( | ||
Other current and noncurrent liabilities | ( | ||
Total identifiable net assets at fair value | |||
Goodwill | |||
Total estimated fair value of net assets | |||
Less: fair value of previously held equity method investment | ( | ||
Net consideration | $ | ||
Acquisitions of business, net of cash acquired | |||
Cash consideration | $ | ||
Less: cash and cash equivalents acquired | ( | ||
Total outflow in the statements of cash flows | $ |
(In millions) | Total 2024 Acquisitions | ||
Total consideration | $ | ||
Total Assets and Liabilities Acquired | |||
Cash and Cash Equivalents | |||
Inventories, net | |||
Property, plant and equipment, net | |||
Intangible assets | |||
Other current and noncurrent assets | |||
Deferred tax liabilities | ( | ||
Other current and noncurrent liabilities | ( | ||
Total identifiable net assets at fair value | |||
Goodwill | |||
Total estimated fair value of net assets | |||
Less: cash acquired | ( | ||
Net consideration | $ | ||
Acquisitions of business, net of cash acquired | |||
Cash consideration | $ | ||
Less: cash and cash equivalents acquired | ( | ||
Total outflow in the statements of cash flows | $ |
(In millions) | Duro-Last | Others | Total 2023 Acquisitions | ||
Total consideration | $ | $ | $ | ||
Total Assets and Liabilities Acquired | |||||
Cash and cash equivalents | $ | $ | $ | ||
Accounts receivable | |||||
Inventories | |||||
Property, plant and equipment | |||||
Operating lease right-of-use assets | |||||
Intangible assets | |||||
Other assets | |||||
Accounts payable | ( | ( | ( | ||
Operating lease liabilities | ( | ( | |||
Deferred income tax liabilities, net | ( | ( | ( | ||
Other liabilities | ( | ( | ( | ||
Total identifiable net assets at fair value | |||||
Goodwill | |||||
Total consideration | $ | $ | $ | ||
Acquisitions of businesses, net of cash acquired | |||||
Cash consideration | $ | $ | $ | ||
Less: cash and cash equivalents acquired | ( | ( | |||
Total outflow in the consolidated statements of cash flows | $ | $ | $ |
(In millions) | Duro-Last | Others | Total 2023 Acquisitions | Weighted-Average Life (in years) | |||
Customer relationships | $ | $ | $ | ||||
Trade names and trademarks | |||||||
Developed technology | |||||||
Others | — | ||||||
Total identified intangible assets | $ | $ | $ |
As of December 31, | ||||
(In millions) | 2025 | 2024 | ||
Trade receivables | $ | $ | ||
Less: allowance for credit losses | ( | ( | ||
Other current receivables, net | ||||
Accounts receivable, net | $ | $ | ||
(In millions) | 2025 | 2024 | 2023 | |||
Balance as of January 1 | $ | $ | $ | |||
Charge-offs | ( | ( | ( | |||
Provision for credit losses | ||||||
Foreign currency translation and other | ( | ( | ||||
Balance as of December 31, | $ | $ | $ |
As of December 31, | ||||
(In millions) | 2025 | 2024 | ||
Raw materials, parts, and supplies | $ | $ | ||
Semi-finished and finished goods | ||||
Total Inventories | $ | $ | ||
As of December 31, | ||||
(In millions) | 2025 | 2024 | ||
Land and mineral reserves | $ | $ | ||
Buildings and installations | ||||
Machines, furniture, vehicles and tools | ||||
Construction in progress | ||||
Finance lease right-of-use assets | ||||
Total property, plant and equipment | ||||
Less: accumulated depreciation, depletion and impairment | ( | ( | ||
Property, plant and equipment, net | $ | $ | ||
(In millions) | Building Materials | Building Envelope | Total | |||
Balance as of January 1, 2024 | $ | $ | $ | |||
Acquisitions | ||||||
Foreign currency translation adjustment and other | ( | ( | ||||
Balance as of December 31, 2024 | $ | $ | $ | |||
Acquisitions | ||||||
Foreign currency translation adjustment and other(1) | ||||||
Balance as of December 31, 2025 | $ | $ | $ |
As of December 31, 2025 | ||||||
(In millions) | Gross carrying amount | Accumulated amortization | Total intangible assets, net | |||
Customer relationships | $ | $( | $ | |||
Mining rights | ( | |||||
Developed technology | ( | |||||
Software | ( | |||||
Trade names and trademarks | ( | |||||
Other intangible assets | ( | |||||
Intangible assets | $ | $( | $ | |||
As of December 31, 2024 | ||||||
(In millions) | Gross carrying amount | Accumulated amortization | Total intangible assets, net | |||
Customer relationships | $ | $( | $ | |||
Mining rights | ( | |||||
Developed technology | ( | |||||
Software | ( | |||||
Trade names and trademarks | ( | |||||
Other intangible assets | ( | |||||
Intangible assets | $ | $( | $ | |||
(In millions) | |
2026 | $ |
2027 | |
2028 | |
2029 | |
2030 | |
Thereafter | |
Total | $ |
As of December 31, | ||||
(In millions) | 2025 | 2024 | ||
Finance lease liabilities | $ | $ | ||
Income tax payable | ||||
Employee-related liabilities other than pension | ||||
Short-term provisions | ||||
Contract liabilities | ||||
Asset retirement obligations | ||||
Pension liabilities | ||||
Accrued purchases of property, plant and equipment | ||||
Self-insurance reserves | ||||
Accrued interest | ||||
Other(1) | ||||
Total Other current liabilities | $ | $ | ||
As of December 31, | ||||
(In millions) | 2025 | 2024 | ||
Liabilities for unrecognized tax benefits | $ | $ | ||
Finance lease liabilities | ||||
Asset retirement obligations | ||||
Pension liabilities | ||||
Contract liabilities | ||||
Environmental remediation liabilities | ||||
Self-insurance reserves | ||||
Other(1) | ||||
Total Other noncurrent liabilities | $ | $ | ||
Effective interest rate as of December 31, | Balance as of December 31, | |||||
(In millions) | 2025 | 2025 | 2024 | |||
$ | $ | |||||
Other | ||||||
Total principal | ||||||
Unamortized (discounts), premiums and debt issuance costs | ( | |||||
Total long-term debt | ||||||
Less: current portion of long-term debt | ( | ( | ||||
Long-term debt | $ | $ | ||||
(In millions) | As of December 31, 2025 | |
Carrying amount | $ | |
Fair value | $ |
(In millions) | ||
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total | $ |
As of December 31, | ||||
(In millions) | 2025 | 2024 | ||
Operating lease right-of-use assets, net | $ | $ | ||
Finance lease right-of-use assets, net | ||||
Total lease assets, net | $ | $ | ||
Current portion of operating lease liabilities | $ | $ | ||
Current portion of finance lease liabilities | ||||
Noncurrent portion of operating lease liabilities | ||||
Noncurrent portion of finance lease liabilities | ||||
Total lease liabilities | $ | $ | ||
(In millions) | Operating Leases | Finance Leases | ||
2026 | $ | $ | ||
2027 | ||||
2028 | ||||
2029 | ||||
2030 | ||||
Thereafter | ||||
Total minimum lease payments | ||||
Less: Lease payments representing interest | ( | ( | ||
Present value of future minimum lease payments | ||||
Less: Current portion of lease liabilities | ( | ( | ||
Noncurrent portion of lease liabilities | $ | $ |
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Operating lease expense | $ | $ | $ | |||
Finance lease expense: | ||||||
Depreciation or amortization of leased assets | ||||||
Interest on lease liabilities | ||||||
Short term lease cost | ||||||
Variable lease cost | ||||||
Total lease expense | $ | $ | $ | |||
As of December 31, | ||||
2025 | 2024 | |||
Weighted-average remaining lease terms (years) | ||||
Operating leases | ||||
Finance leases | ||||
Weighted-average discount rate (%) | ||||
Operating leases | ||||
Finance leases | ||||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Accretion | $ | $ | $ | |||
Depreciation | ||||||
Total costs | $ | $ | $ | |||
As of December 31, | ||||
2025 | 2024 | |||
Current ARO liability | $ | $ | ||
Noncurrent ARO liability | ||||
Total ARO liability | $ | $ | ||
(In millions) | 2025 | 2024 | ||
Balance as of January 1 | $ | $ | ||
Accretion expense | ||||
Liabilities incurred and acquired | ||||
Liabilities settled | ( | ( | ||
Changes in estimate and acquisitions, net | ( | |||
Foreign currency translation adjustment | ( | |||
Balance as of December 31 | $ | $ |
For the years ended December 31, | |||||
(In millions) | 2025 | 2024 | 2023 | ||
Swiss | $ | $ | $ | ||
Non-Swiss | |||||
Total income before income tax expense and income from equity method investments | $ | $ | $ | ||
For the years ended December 31, | |||||
(In millions) | 2025 | 2024 | 2023 | ||
Current: | |||||
Swiss – Federal | $ | $ | $ | ||
Swiss – Cantonal | |||||
Non-Swiss | |||||
Total current tax expense | |||||
Deferred: | |||||
Swiss – Federal | ( | ||||
Swiss – Cantonal | |||||
Non-Swiss | ( | ( | |||
Total deferred tax expense (benefit) | ( | ||||
Total income tax expense | $ | $ | $ | ||
For the years ended December 31, | ||||||
(In millions, except for percentage data) | 2025 | % | 2024 | % | 2023 | % |
Swiss federal statutory tax rate | $ | $ | $ | |||
Cantonal income taxes (1) | ||||||
Changes in unrecognized tax benefits | ( | ( | ||||
OECD Pillar Two tax | ( | ( | ||||
Other adjustments: | ||||||
Deferred tax adjustments | ||||||
Other | ( | ( | ( | ( | ||
Foreign tax effects | ||||||
United States | ||||||
Effect of rates different than statutory | ||||||
State and local income taxes | ||||||
Nontaxable or nondeductible items | ||||||
Other adjustments: | ||||||
Percentage depletion | ( | ( | ( | ( | ( | ( |
Deferred tax adjustments | ( | ( | ||||
Purchase price adjustments | ( | ( | ||||
Other | ( | ( | ( | ( | ||
Canada | ||||||
Effect of rates different than statutory | ||||||
State and local income taxes | ||||||
Nontaxable or nondeductible items | ||||||
Other adjustments: | ||||||
Repatriation cost | ||||||
Other | ( | ( | ||||
Other foreign jurisdictions: | ||||||
Other adjustments | ||||||
Total income tax expense | $ | $ | $ | |||
Effective income tax rate | ||||||
For the years ended December 31, | |||||
(In millions) | 2025 | 2024 | 2023 | ||
Swiss | $ | $ | $ | ||
United States | |||||
Canada | |||||
Total income taxes paid | $ | $ | $ | ||
As of December 31, | |||
(In millions) | 2025 | 2024 | |
Deferred tax assets: | |||
Deferred expenses and defined benefit pension plan obligations | $ | $ | |
Lease liabilities | |||
Site restoration | |||
Net operating loss | |||
Other assets | |||
Total deferred tax assets | |||
Less: valuation allowances | ( | ( | |
Total deferred tax assets after valuation allowances | $ | $ | |
Deferred tax liabilities: | |||
Cost depletion | $( | $( | |
Property, plant and equipment | ( | ( | |
Intangible and other long-lived assets | ( | ( | |
Leased right-of-use assets | ( | ( | |
Other liabilities | ( | ||
Total deferred tax liabilities | ( | ( | |
Total net deferred tax liabilities | $( | $( | |
Reported as: | |||
Deferred tax liabilities | $( | $( | |
Other noncurrent assets | |||
Deferred tax liabilities, net | $( | $( | |
(In millions) | 2025 | 2024 | 2023 | ||
Balance as of January 1 | $ | $ | $ | ||
Increase (decrease) charged to tax expense | |||||
Currency translation and other | |||||
Balance as of December 31 | $ | $ | $ |
(In millions) | 2025 | 2024 | 2023 | ||
Balance as of January 1 | $ | $ | $ | ||
Increases related to current period tax positions | |||||
Increases related to prior period tax positions | |||||
Decreases related to prior period tax positions | ( | ( | |||
Decreases related to lapses in statutes of limitations | ( | ( | ( | ||
Balance as of December 31 | $ | $ | $ |
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Revenues: | ||||||
Building Materials | $ | $ | $ | |||
Building Envelope | ||||||
Total Revenues | $ | $ | $ | |||
Cost of revenues: | ||||||
Building Materials | $ | $ | $ | |||
Building Envelope | ||||||
Total cost of revenues | $ | $ | $ | |||
Other segment expenses(1): | ||||||
Building Materials | $ | $ | $ | |||
Building Envelope | ||||||
Total other segment expenses | $ | $ | $ | |||
Segment Adjusted EBITDA: | ||||||
Building Materials | $ | $ | $ | |||
Building Envelope | ||||||
Total Segment Adjusted EBITDA | $ | $ | $ | |||
Reconciling items: | ||||||
Depreciation, depletion, accretion and amortization | ( | ( | ( | |||
Interest income | ||||||
Interest expense | ( | ( | ( | |||
Acquisition and integration-related costs(2) | ( | ( | ( | |||
Litigation-related costs(3) | ( | ( | ( | |||
Loss on impairments(4) | ( | ( | ( | |||
Restructuring and other costs(5) | ( | ( | ( | |||
Spin-off and separation-related costs(6) | ( | ( | ||||
Unallocated corporate costs | ( | ( | ( | |||
Other non-operating income (expense), net(7) | ( | ( | ||||
Total reconciling items | ( | ( | ( | |||
Income before income tax expense and income from equity method investments | $ | $ | $ | |||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Capital expenditures(1): | ||||||
Building Materials | $ | $ | $ | |||
Building Envelope | ||||||
Total capital expenditures | $ | $ | $ | |||
As of December 31, | ||||
(In millions) | 2025 | 2024 | ||
Segment assets(1): | ||||
Building Materials | $ | $ | ||
Building Envelope | ||||
Total segment assets | ||||
Other assets(2) | ||||
Total assets | $ | $ | ||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Revenues: | ||||||
United States | $ | $ | $ | |||
Canada | ||||||
Other | ||||||
Total revenues | $ | $ | $ | |||
As of December 31, | ||||
(In millions) | 2025 | 2024 | ||
Long-lived assets by geographical area (1) : | ||||
United States | $ | $ | ||
Canada | ||||
Other | ||||
Total long-lived assets by geographical area | $ | $ | ||
As of December 31, | |||||||
2025 | 2024 | ||||||
(In millions, except for percentage data) | U.S. | Non-U.S. | U.S. | Non-U.S. | |||
Change in benefit obligation: | |||||||
Benefit obligation, beginning of year | $ | $ | $ | $ | |||
Service cost | |||||||
Interest cost | |||||||
Actuarial (gains) and losses | ( | ||||||
Benefits paid | ( | ( | ( | ( | |||
Settlements | ( | ||||||
Foreign currency rate changes | ( | ||||||
Plan transfer in | |||||||
Benefit obligation, end of year | $ | $ | $ | $ | |||
Change in fair value of plan assets: | |||||||
Fair value of plan assets, beginning of year | $ | $ | $ | $ | |||
Actual return on plan assets | |||||||
Employer contributions | |||||||
Plan transfer in | |||||||
Benefits paid | ( | ( | ( | ( | |||
Settlements | ( | ||||||
Foreign currency rate changes | ( | ||||||
Fair value of plan assets, end of year | |||||||
Funded status | $( | $( | $( | $( | |||
Amounts recognized on the consolidated balance sheets: | |||||||
Noncurrent assets | $ | $ | $ | $ | |||
Current liabilities | ( | ( | ( | ( | |||
Noncurrent liabilities | ( | ( | ( | ( | |||
Funded status at end of year | $( | $( | $( | $( | |||
As of December 31, | |||||||
2025 | 2024 | ||||||
(In millions, except for percentage data) | U.S. | Non-U.S. | U.S. | Non-U.S. | |||
Amounts recognized in Accumulated other comprehensive loss: | |||||||
Net actuarial (gain) loss | $( | $ | $( | $ | |||
Total | $( | $ | $( | $ | |||
Weighted-average assumptions used to determine benefit obligations: | |||||||
Discount rate | |||||||
Rate of compensation increase | |||||||
Interest crediting rate | |||||||
For the years ended December 31, | |||||||||||
2025 | 2024 | 2023 | 2025 | 2024 | 2023 | ||||||
(In millions, except for percentage data) | U.S. | Non-U.S. | |||||||||
Components of Net periodic benefit cost (credit): | |||||||||||
Service cost | $ | $ | $ | $ | $ | $ | |||||
Interest cost | |||||||||||
Expected return on assets | ( | ( | ( | ( | |||||||
Amortization of actuarial (gains) | ( | ( | |||||||||
Settlement loss | |||||||||||
Net periodic benefit cost | $ | $ | $ | $ | $ | $ | |||||
Changes in plan assets and benefit obligations recognized in Other comprehensive (income) loss: | |||||||||||
Net actuarial (gain) loss | $ | $( | $ | $( | $ | $ | |||||
Amortization of actuarial loss (gain) | ( | ( | |||||||||
Foreign currency rate changes | ( | ||||||||||
Total recognized in Other comprehensive (income) loss | ( | ( | ( | ||||||||
Total recognized in Net periodic benefit cost and Other comprehensive (income) loss | $ | $ | $ | $ | $ | $ | |||||
Weighted-average assumptions used to determine Net periodic benefit cost (credit): | |||||||||||
Discount rate | |||||||||||
Rate of compensation increase | |||||||||||
Expected long-term rate of return on plan assets | |||||||||||
Interest crediting rate | |||||||||||
As of December 31, | |||||||
2025 | 2024 | ||||||
(In millions) | U.S. | Non-U.S. | U.S. | Non-U.S. | |||
Defined benefit pension plans with projected benefit obligations in excess of plan assets: | |||||||
Projected benefit obligation | $ | $ | $ | $ | |||
Fair value of plan assets | $ | $ | $ | $ | |||
As of December 31, | |||||||
2025 | 2024 | ||||||
(In millions, except for percentage data) | U.S. | Non-U.S. | U.S. | Non-U.S. | |||
Change in benefit obligation: | |||||||
Benefit obligation, beginning of year | $ | $ | $ | $ | |||
Service cost | |||||||
Interest cost | |||||||
Actuarial (gains) | ( | ( | ( | ||||
Benefits paid | ( | ( | ( | ( | |||
Foreign currency rate changes | ( | ||||||
Benefit obligation, end of year | $ | $ | $ | $ | |||
Change in fair value of plan assets: | |||||||
Fair value of plan assets, beginning of year | $ | $ | $ | $ | |||
Employer contributions | |||||||
Benefits paid | ( | ( | ( | ( | |||
Fair value of plan assets, end of year | |||||||
Funded status | $( | $( | $( | $( | |||
Amounts recognized on the consolidated balance sheets: | |||||||
Current liabilities | $( | $( | $( | $( | |||
Noncurrent liabilities | ( | ( | ( | ( | |||
Funded status at end of year | $( | $( | $( | $( | |||
Amounts recognized in Accumulated other comprehensive loss: | |||||||
Net actuarial (gains) | $( | $( | $( | $( | |||
Total | $( | $( | $( | $( | |||
Weighted-average assumptions used to determine benefit obligations: | |||||||
Discount rate | |||||||
For the years ended December 31, | |||||||||||
2025 | 2024 | 2023 | 2025 | 2024 | 2023 | ||||||
(In millions, except for percentage data) | U.S. | Non-U.S. | |||||||||
Components of Net periodic benefit cost: | |||||||||||
Service cost | $ | $ | $ | $ | $ | $ | |||||
Interest cost | |||||||||||
Amortization of actuarial (gains) | ( | ( | ( | ( | ( | ||||||
Net periodic benefit cost | $ | $ | $ | $ | $ | $ | |||||
Changes in plan assets and benefit obligations recognized in Other comprehensive (income) loss: | |||||||||||
Net actuarial (gain) loss | $( | $( | $( | $( | $ | $ | |||||
Amortization of actuarial loss | |||||||||||
Foreign currency rate changes | |||||||||||
Total recognized in Other comprehensive (income) loss | $ | $ | $( | $( | $ | $ | |||||
Total recognized in Net periodic benefit cost and Other comprehensive (income) loss | $ | $ | $ | $ | $ | $ | |||||
Weighted-average assumptions used to determine Net periodic benefit cost: | |||||||||||
Discount rate | |||||||||||
For the years ended December 31, | |||||||||||
U.S. | Non-U.S. | ||||||||||
2025 | 2024 | 2023 | 2025 | 2024 | 2023 | ||||||
Healthcare cost trend rate assumed for next year | |||||||||||
Rate to which the cost trend rate gradually declines | |||||||||||
Year the rate reaches the ultimate rate | |||||||||||
As of December 31, | |||||||
2025 | 2024 | ||||||
(In millions) | U.S. | Non-U.S. | U.S. | Non-U.S. | |||
Other postretirement benefit plans with accumulated postretirement benefit obligations in excess of plan assets: | |||||||
Accumulated postretirement benefit obligation | $ | $ | $ | $ | |||
(In millions) | Defined Benefit Pension Plans 2025(1) | |
Cash and cash equivalents | ||
Equity instruments | ||
Debt instruments | ||
Other |
Defined Benefit Pension Plans Fair Values | |||||||
As of December 31, 2025 | |||||||
Non-U.S. Plans | |||||||
(In millions) | Level 1 | Level 2 | Level 3 | Total | |||
Cash and cash equivalents | $ | $ | $ | $ | |||
Equity instruments | |||||||
Debt instruments | |||||||
Other | |||||||
Insurance contracts | |||||||
Total | $ | $ | $ | $ | |||
Defined Benefit Pension Plans Fair Values | |||||||
As of December 31, 2024 | |||||||
Non-U.S. Plans | |||||||
(In millions) | Level 1 | Level 2 | Level 3 | Total | |||
Cash and cash equivalents | $ | $ | $ | $ | |||
Equity instruments | |||||||
Debt instruments | |||||||
Insurance contracts | |||||||
Total | $ | $ | $ | $ | |||
For the year ended December 31, 2025 | |||||||||
Non-U.S. Plans | |||||||||
(In millions) | Beginning Balance | Actual return on plan assets, relating to assets still held at reporting date | Purchases, sales and settlements | Change due to exchange rate changes | Ending Balance | ||||
Equity instruments | $ | $ | $ | $ | $ | ||||
Insurance contracts | ( | ||||||||
Total | $ | $ | $( | $ | $ | ||||
For the year ended December 31, 2024 | |||||||||
Non-U.S. Plans | |||||||||
(In millions) | Beginning Balance | Actual return on plan assets, relating to assets still held at reporting date | Purchases, sales and settlements | Change due to exchange rate changes | Ending Balance | ||||
Equity instruments | $ | $ | $( | $ | $ | ||||
Insurance contracts | ( | ( | |||||||
Total | $ | $ | $( | $( | $ | ||||
Defined Benefit Pension Plans | Other Postretirement Benefit Plans | ||||||
(In millions) | U.S. | Non-U.S. | U.S. | Non-U.S. | |||
2026 | $ | $ | $ | $ | |||
2027 | |||||||
2028 | |||||||
2029 | |||||||
2030 | |||||||
2031-2035 | |||||||
(In millions) | Foreign Currency Translation Adjustment | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Total | ||||
Balance as of January 1, 2023 | $( | $ | $ | $( | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified from Accumulated other comprehensive income (loss) to Net income | ( | ( | ||||||
Net current-period Other comprehensive income (loss) | ( | ( | ||||||
Balance as of December 31, 2023 | ( | ( | ( | ( | ||||
Other comprehensive income (loss) before reclassifications | ( | ( | ||||||
Amounts reclassified from Accumulated other comprehensive income (loss) to Net income | ( | |||||||
Net current-period Other comprehensive income (loss) | ( | ( | ||||||
Balance as of December 31, 2024 | ( | ( | ( | |||||
Other comprehensive income (loss) before reclassifications | ||||||||
Amounts reclassified from Accumulated other comprehensive income (loss) to Net income | ( | ( | ( | |||||
Net current-period Other comprehensive income (loss) | ||||||||
Unrecognized gain transferred from Holcim pension | ||||||||
Balance as of December 31, 2025 | $( | $( | $ | $( |
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Net change in fair value of effective portion of cash flow hedges | ||||||
Cost of revenues | $( | $( | $( | |||
Income tax expense | ||||||
Total | $( | $( | $( | |||
Actuarial losses and prior service costs for defined benefit pension plans and other postretirement benefit plans | ||||||
Other non-operating (income) expense, net | $( | $ | $ | |||
Income tax expense (benefit) | ( | ( | ||||
Total | $( | $ | $ | |||
Total amounts reclassified from Accumulated other comprehensive income (loss) to Net income | $( | $ | $( | |||
(In millions) | 2025 | 2024 | ||
Balance as of January 1 | $ | $ | ||
Increase for warranties issued | ||||
Increase for pre-existing warranties | ||||
Decrease for payments | ( | ( | ||
Balance as of December 31 | $ | $ |
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Cost of revenues | $ | $ | $ | |||
Selling, general and administrative expenses | ||||||
Total | $ | $ | $ | |||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Net transfers to Holcim as reflected on the consolidated statements of cash flows(1) | $( | $( | $( | |||
Equity contribution from Holcim related to the settlement of Related-party notes payable | ||||||
Other non-cash activities with Holcim, net(2) | ||||||
Net transfers from (to) Holcim as reflected on the consolidated statements of equity | $ | $( | $( | |||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Interest paid | $ | $ | $ | |||
Income taxes paid | ||||||
Operating cash flows used for operating leases | ( | ( | ( | |||
Operating cash flows used for finance leases | ( | ( | ( | |||
Financing cash flows used for finance leases | ( | ( | ( | |||
For the years ended December 31, | ||||||
(In millions) | 2025 | 2024 | 2023 | |||
Accrued purchases of property, plant and equipment | $ | $ | $ | |||
Right-of-use assets obtained in exchange for new operating lease liabilities | ||||||
Right-of-use assets obtained in exchange for new finance lease liabilities | ||||||
Equity contribution from Holcim related to the Spin-off | ||||||
For the years ended December 31, | ||||||
(In millions, except per share data) | 2025 | 2024 | 2023 | |||
Numerator: | ||||||
Net income | $ | $ | $ | |||
Net loss attributable to noncontrolling interest | ||||||
Net income attributable to the Company | $ | $ | $ | |||
Denominator: | ||||||
Basic weighted-average number of shares outstanding | ||||||
Dilutive effect of share-based awards | ||||||
Diluted weighted-average number of shares outstanding | ||||||
Earnings per share | ||||||
Basic | $ | $ | $ | |||
Diluted | $ | $ | $ | |||
(In millions, except per share data, units in actual) | Number of Units | Weighted Average Grant Date Fair Value | |
Nonvested as of December 31, 2024 | $ | ||
Awards converted upon Spin-Off | |||
Granted | |||
Vested | |||
Forfeited | |||
Nonvested as of December 31, 2025 | $ |
(In millions, except per share data, units in actual) | Number of Units (1) | Weighted Average Grant Date Fair Value | |
Nonvested as of December 31, 2024 | $ | ||
Awards converted upon Spin-Off | |||
Granted | |||
Vested | ( | ||
Forfeited | ( | ||
Nonvested as of December 31, 2025 | $ |
2025 | ||
Expected volatility | ||
Expected dividend yield | ||
Risk-free interest rates | ||
Remaining performance period |
(In millions, except per share data, options in actual) | Number of Stock Options | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value | |||
Outstanding as of December 31, 2024 | $ | ||||||
Awards converted upon Spin-off | |||||||
Exercised | |||||||
Forfeited | ( | ||||||
Expired | |||||||
Outstanding as of December 31, 2025 | $ | $ | |||||
Vested and expected to vest, December 31, 2025 | $ | $ | |||||
Exercisable as of December 31, 2025 | $ | $ |
Ownership percentage | Balance as of December 31, | Share of income for the year ended December 31, | |||||||||
(In millions, except for percentage data) | 2025 | 2024 | 2025 | 2024 | 2023 | ||||||
Quality Concrete Inc. | $ | $ | $ | $ | $ | ||||||
Nelson Aggregate Co Partnership | |||||||||||
Others | |||||||||||
Total | $ | $ | $ | $ | $ | ||||||
Exhibit No. | Exhibit |
2.1# | |
3.1 | |
3.2 | |
4.1* | |
4.2 | |
4.3 | |
4.4 | |
4.5 | |
4.6 | |
4.7 | |
4.8 | |
4.9 | |
4.9 | |
4.10* | |
4.11* | |
4.12* | |
4.13* | |
4.14* | |
4.15* | |
4.16 |
Exhibit No. | Exhibit |
4.17 | |
4.18 | |
4.19* | |
4.20* | |
4.21* | |
4.22* | |
4.23 | |
10.1& | |
10.2& | |
10.3# | |
10.4# | |
10.5 | |
10.6# | |
10.7# | |
10.8#† | |
10.9#† | |
10.10 | |
10.11& | |
10.12& | |
10.13& | |
10.14& | |
10.15& |
Exhibit No. | Exhibit |
10.16& | |
10.17*&# | |
10.18*&# | |
10.19*& | |
10.20*& | |
10.21*& | |
10.22*& | |
10.23*& | |
10.24*&# | |
10.25*& | |
10.26*&# | |
10.27*&# | |
10.28*& | |
19* | |
21* | |
22* | |
23.1 | |
31.1* | |
31.2* | |
32.1** | |
95* | |
97* | |
101* | Inline eXtensible Business Reporting Language (XBRL). |
104 | Cover Page Interactive Data File (formatted in iXBRL in Exhibit 101) |
Amrize Ltd | ||||
By: | /s/ Jan Jenisch | |||
Name: | Jan Jenisch | |||
Title: | Chief Executive Officer and Chairman (Principal Executive Officer) | |||
Date: | February 18, 2026 | |||
Name | Title | Date |
/s/Jan Philipp Jenisch | Chief Executive Officer and Chairman (Principal Executive Officer) | February 18, 2026 |
Jan Philipp Jenisch | ||
/s/Ian Johnston | Chief Financial Officer (Principal Financial Officer) | February 18, 2026 |
Ian Johnston | ||
/s/Richard Hoffman | Chief Accounting Officer and Corporate Controller (Principal Accounting Officer) | February 18, 2026 |
Richard Hoffman | ||
/s/Nicholas Gangestad | Director | February 18, 2026 |
Nicholas Gangestad | ||
/s/Dwight Gibson | Director | February 18, 2026 |
Dwight Gibson | ||
/s/Holli Ladhani | Director | February 18, 2026 |
Holli Ladhani | ||
/s/Michael E. McKelvy | Director | February 18, 2026 |
Michael E. McKelvy | ||
/s/Jürg Oleas | Director | February 18, 2026 |
Jürg Oleas | ||
/s/Robert S. Rivkin | Director | February 18, 2026 |
Robert S. Rivkin | ||
/s/Katja Roth Pellanda | Director | February 18, 2026 |
Katja Roth Pellanda | ||
/s/Maria Cristina A. Wilbur | Director | February 18, 2026 |
Maria Cristina A. Wilbur |